[HTML][HTML] Tumor microenvironment, a paradigm in hepatocellular carcinoma progression and therapy

M Tahmasebi Birgani, V Carloni - International journal of molecular …, 2017 - mdpi.com
Hepatocellular carcinoma (HCC) is among the most lethal and prevalent cancers in the
human population. Different etiological factors such as hepatitis B and C virus, alcohol and …

Leptin in nonalcoholic fatty liver disease: a narrative review

SA Polyzos, J Kountouras, CS Mantzoros - Metabolism, 2015 - Elsevier
Leptin, the first described adipokine, interplays with hepatic metabolism. The aim of this
review was to summarize available data on the association between leptin and nonalcoholic …

[HTML][HTML] Role of leptin in non-alcoholic fatty liver disease

C Jiménez-Cortegana, A García-Galey, M Tami… - Biomedicines, 2021 - mdpi.com
Non-alcoholic fatty liver disease (NAFLD), which affects about a quarter of the global
population, poses a substantial health and economic burden in all countries, yet there is no …

[HTML][HTML] Molecular mechanism contributing to malnutrition and sarcopenia in patients with liver cirrhosis

F Meyer, K Bannert, M Wiese, S Esau… - International journal of …, 2020 - mdpi.com
Liver cirrhosis is frequently accompanied by disease-related malnutrition (DRM) and
sarcopenia, defined as loss of skeletal muscle mass and function. DRM and sarcopenia …

[HTML][HTML] Roles of adipokines in digestive diseases: markers of inflammation, metabolic alteration and disease progression

ML Chang, Z Yang, SS Yang - International journal of molecular sciences, 2020 - mdpi.com
Adipose tissue is a highly dynamic endocrine tissue and constitutes a central node in the
interorgan crosstalk network through adipokines, which cause pleiotropic effects, including …

Ghrelin gene products and the regulation of food intake and gut motility

CY Chen, A Asakawa, M Fujimiya, SD Lee… - Pharmacological reviews, 2009 - ASPET
A breakthrough using “reverse pharmacology” identified and characterized acyl ghrelin from
the stomach as the endogenous cognate ligand for the growth hormone (GH) secretagogue …

[HTML][HTML] Deletion of interleukin-6 in monocytes/macrophages suppresses the initiation of hepatocellular carcinoma in mice

L Kong, Y Zhou, H Bu, T Lv, Y Shi, J Yang - Journal of Experimental & …, 2016 - Springer
Background Hepatocellular carcinoma (HCC) is associated with inflammation, and roughly
30% of the global population shows serological evidence of current or past infection with …

Effects of interleukin-6 (IL-6) and an anti-IL-6 monoclonal antibody on drug-metabolizing enzymes in human hepatocyte culture

LJ Dickmann, SK Patel, DA Rock, LC Wienkers… - Drug Metabolism and …, 2011 - ASPET
The cytokine-mediated suppression of hepatic drug-metabolizing enzymes by inflammatory
disease and the relief of this suppression by successful disease treatment have recently …

High serum interleukin‐6 level predicts future hepatocellular carcinoma development in patients with chronic hepatitis B

VWS Wong, J Yu, ASL Cheng… - … journal of cancer, 2009 - Wiley Online Library
Abstract Increased interleukin‐6 (IL‐6) production is implicated in the pathogenesis of
hepatocellular carcinoma (HCC) in animal models. Although previous studies showed that …

[HTML][HTML] Adipokines in liver cirrhosis

C Buechler, EM Haberl, L Rein-Fischboeck… - International journal of …, 2017 - mdpi.com
Liver fibrosis can progress to cirrhosis, which is considered a serious disease. The Child-
Pugh score and the model of end-stage liver disease score have been established to assess …